Correction: Skin Pharmacokinetics of Transdermal Scopolamine: Measurements and Modeling (Molecular Pharmaceutics (2021) 18:7 (2714-2723) DOI: 10.1021/acs.molpharmaceut.1c00238)

Andrea Pensado; Laura Hattam; K. A.Jane White; Anita McGrogan; Annette L. Bunge; Richard H. Guy; M. Begoña Delgado-Charro

doi:10.1021/acs.molpharmaceut.2c00400

Correction: Skin Pharmacokinetics of Transdermal Scopolamine: Measurements and Modeling (Molecular Pharmaceutics (2021) 18:7 (2714-2723) DOI: 10.1021/acs.molpharmaceut.1c00238)

Andrea Pensado, Laura Hattam, K. A.Jane White, Anita McGrogan, Annette L. Bunge, Richard H. Guy, M. Begoña Delgado-Charro

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The headings for two parameter values in Table 2 of the original paper were lost during the publishing process. Thus, to avoid any confusion, the authors clarify that the value listed as 0.04 corresponds to the parameter β (h^-1) and the value listed as 0.21 corresponds to the parameter δ (h^-1) as correctly described in the text of the original paper and presented in the corrected Table 2 shown below.(Table Presented).

Original language	English
Pages (from-to)	2681-2682
Number of pages	2
Journal	Molecular Pharmaceutics
Volume	19
Issue number	7
Early online date	3 Jun 2022
DOIs	https://doi.org/10.1021/acs.molpharmaceut.2c00400
Publication status	Published - 4 Jul 2022

Bibliographical note

Publisher Copyright:
© 2022 American Chemical Society. All rights reserved.

ASJC Scopus subject areas

Molecular Medicine
Pharmaceutical Science
Drug Discovery

Access to Document

10.1021/acs.molpharmaceut.2c00400

Cite this

Pensado, A., Hattam, L., White, K. A. J., McGrogan, A., Bunge, A. L., Guy, R. H., & Delgado-Charro, M. B. (2022). Correction: Skin Pharmacokinetics of Transdermal Scopolamine: Measurements and Modeling (Molecular Pharmaceutics (2021) 18:7 (2714-2723) DOI: 10.1021/acs.molpharmaceut.1c00238). Molecular Pharmaceutics, 19(7), 2681-2682. https://doi.org/10.1021/acs.molpharmaceut.2c00400

Correction: Skin Pharmacokinetics of Transdermal Scopolamine: Measurements and Modeling (Molecular Pharmaceutics (2021) 18:7 (2714-2723) DOI: 10.1021/acs.molpharmaceut.1c00238). / Pensado, Andrea; Hattam, Laura ; White, K. A.Jane et al.
In: Molecular Pharmaceutics, Vol. 19, No. 7, 04.07.2022, p. 2681-2682.

Research output: Contribution to journal › Comment/debate › peer-review

Pensado, A, Hattam, L , White, KAJ , McGrogan, A, Bunge, AL, Guy, RH & Delgado-Charro, MB 2022, 'Correction: Skin Pharmacokinetics of Transdermal Scopolamine: Measurements and Modeling (Molecular Pharmaceutics (2021) 18:7 (2714-2723) DOI: 10.1021/acs.molpharmaceut.1c00238)', Molecular Pharmaceutics, vol. 19, no. 7, pp. 2681-2682. https://doi.org/10.1021/acs.molpharmaceut.2c00400

@article{26fd0d7ba8904f06aa1b2ef990abb7d5,

title = "Correction: Skin Pharmacokinetics of Transdermal Scopolamine: Measurements and Modeling (Molecular Pharmaceutics (2021) 18:7 (2714-2723) DOI: 10.1021/acs.molpharmaceut.1c00238)",

abstract = "The headings for two parameter values in Table 2 of the original paper were lost during the publishing process. Thus, to avoid any confusion, the authors clarify that the value listed as 0.04 corresponds to the parameter β (h-1) and the value listed as 0.21 corresponds to the parameter δ (h-1) as correctly described in the text of the original paper and presented in the corrected Table 2 shown below.(Table Presented).",

author = "Andrea Pensado and Laura Hattam and White, {K. A.Jane} and Anita McGrogan and Bunge, {Annette L.} and Guy, {Richard H.} and Delgado-Charro, {M. Bego{\~n}a}",

year = "2022",

month = jul,

day = "4",

doi = "10.1021/acs.molpharmaceut.2c00400",

language = "English",

volume = "19",

pages = "2681--2682",

journal = "Molecular Pharmaceutics",

issn = "1543-8384",

publisher = "American Chemical Society",

number = "7",

}

TY - JOUR

T1 - Correction

T2 - Skin Pharmacokinetics of Transdermal Scopolamine: Measurements and Modeling (Molecular Pharmaceutics (2021) 18:7 (2714-2723) DOI: 10.1021/acs.molpharmaceut.1c00238)

AU - Pensado, Andrea

AU - Hattam, Laura

AU - White, K. A.Jane

AU - McGrogan, Anita

AU - Bunge, Annette L.

AU - Guy, Richard H.

AU - Delgado-Charro, M. Begoña

PY - 2022/7/4

Y1 - 2022/7/4

N2 - The headings for two parameter values in Table 2 of the original paper were lost during the publishing process. Thus, to avoid any confusion, the authors clarify that the value listed as 0.04 corresponds to the parameter β (h-1) and the value listed as 0.21 corresponds to the parameter δ (h-1) as correctly described in the text of the original paper and presented in the corrected Table 2 shown below.(Table Presented).

AB - The headings for two parameter values in Table 2 of the original paper were lost during the publishing process. Thus, to avoid any confusion, the authors clarify that the value listed as 0.04 corresponds to the parameter β (h-1) and the value listed as 0.21 corresponds to the parameter δ (h-1) as correctly described in the text of the original paper and presented in the corrected Table 2 shown below.(Table Presented).

UR - http://www.scopus.com/inward/record.url?scp=85132068065&partnerID=8YFLogxK

U2 - 10.1021/acs.molpharmaceut.2c00400

DO - 10.1021/acs.molpharmaceut.2c00400

M3 - Comment/debate

C2 - 35657274

AN - SCOPUS:85132068065

SN - 1543-8384

VL - 19

SP - 2681

EP - 2682

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

IS - 7

ER -

Correction: Skin Pharmacokinetics of Transdermal Scopolamine: Measurements and Modeling (Molecular Pharmaceutics (2021) 18:7 (2714-2723) DOI: 10.1021/acs.molpharmaceut.1c00238)

Abstract

Bibliographical note

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this